General Information of Drug Therapeutic Target (DTT) (ID: TT2LVK8)

DTT Name Carbonic anhydrase IX (CA-IX)
Synonyms
Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; PMW1; P54/58N; Membrane antigen MN; MN; G250 antigen (MN/CA IX/G250); G250; Carbonic anhydrase 9; Carbonate dehydratase IX; CAIX
Gene Name CA9
DTT Type
Clinical trial target
[1]
Related Disease
Solid tumour/cancer [ICD-11: 2A00-2F9Z]
BioChemical Class
Alpha-carbonic anhydrase
UniProt ID
CAH9_HUMAN
TTD ID
T64567
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 4.2.1.1
Sequence
MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQRLPRMQEDSPLGGGSSGEDDPL
GEEDLPSEEDSPREEDPPGEEDLPGEEDLPGEEDLPEVKPKSEEEGSLKLEDLPTVEAPG
DPQEPQNNAHRDKEGDDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFCPALRPL
ELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHT
VEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIA
EEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLS
DTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVDSSPRAAEPVQLNSCLAAGDILALVF
GLLFAVTSVAFLVQMRRQHRRGTKGGVSYRPAEVAETGA
Function
Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia. Reversible hydration of carbon dioxide.
KEGG Pathway
( )
Reactome Pathway
Reversible hydration of carbon dioxide (R-HSA-1475029 )
Regulation of gene expression by Hypoxia-inducible Factor (R-HSA-1234158 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
9 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [2]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [3]
Phenol DM1QSM3 N. A. N. A. Phase 2/3 [2]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [4]
Girentuximab I-124 DMG3O2Z Renal cell carcinoma 2C90 Phase 2 [5], [6]
Indisulam DM9SX6Y Lymphoma 2A80-2A86 Phase 2 [7], [8]
90Y-cG250 DMJR6TC Solid tumour/cancer 2A00-2F9Z Phase 1 [9]
BAY 79-4620 DM14XQN Solid tumour/cancer 2A00-2F9Z Phase 1 [10]
SULFAMIDE DMMAS3K N. A. N. A. Phase 1 [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Clinical Trial Drug(s)
6 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ferulic Acid DMJC7NF Discovery agent N.A. Patented [3]
PMID30074415-Compound-12 DM7K3A0 N. A. N. A. Patented [12]
PMID30074415-Compound-GS3 DM2G8DN N. A. N. A. Patented [12]
Sulfonamide derivative 12 DMXEL56 N. A. N. A. Patented [12]
Sulfonamide-thiadiazole derivative 1 DMP9Z34 N. A. N. A. Patented [12]
Sulfonamide-thiadiazole derivative 2 DMZAE78 N. A. N. A. Patented [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Patented Agent(s)
2 Discontinued Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
CA9-ADC DMSTN6W Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 1 [10]
Spermine DMD4BFY N. A. N. A. Terminated [13]
------------------------------------------------------------------------------------
168 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
(2-bromophenyl)difluoromethanesulfonamide DMFX9H8 Discovery agent N.A. Investigative [14]
(4-bromophenyl)difluoromethanesulfonamide DMOCYZJ Discovery agent N.A. Investigative [14]
(4-sulfamoylphenylethylthioureido)fluorescein DMGCZOI Discovery agent N.A. Investigative [15]
1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide DMNHGVD Discovery agent N.A. Investigative [16]
1,4-phenylene disulfamate DMEDBO2 Discovery agent N.A. Investigative [17]
1-(3,4-dichlorophenyl)-3-hydroxyurea DMVOJ7K Discovery agent N.A. Investigative [18]
1-acetamido-5-sulfonamidoindane DM92ZCU Discovery agent N.A. Investigative [19]
1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide DMUXSH5 Discovery agent N.A. Investigative [16]
1-cyclohexylamido-5-sulfonamidoindane DMFPQME Discovery agent N.A. Investigative [19]
1-pentafluorophenylamido-5-sulfonamidoindane DM9PNTQ Discovery agent N.A. Investigative [19]
1-valproylamido-5-sulfonamidoindane DM9ZRU2 Discovery agent N.A. Investigative [19]
2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide DMG4ITB Discovery agent N.A. Investigative [20]
2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide DMATB8H Discovery agent N.A. Investigative [20]
2,4-Disulfamyltrifluoromethylaniline DM2AW0Z Discovery agent N.A. Investigative [21]
2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide DM1JKWL Discovery agent N.A. Investigative [22]
2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide DMFGQ7K Discovery agent N.A. Investigative [22]
2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide DMRADWB Discovery agent N.A. Investigative [22]
2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide DMSNCOW Discovery agent N.A. Investigative [22]
2-(benzyloxyamino)-N-hydroxyacetamide DMHZJXG Discovery agent N.A. Investigative [22]
2-(benzyloxyamino)-N-hydroxyhexanamide DMOUKTH Discovery agent N.A. Investigative [22]
2-(N''-Acetyl-hydrazino)-benzenesulfonamide DMHYKR8 Discovery agent N.A. Investigative [23]
2-acetamido-5-sulfonamidoindane DMPKBVR Discovery agent N.A. Investigative [19]
2-Amino-benzenesulfonamide DMEMANH Discovery agent N.A. Investigative [21]
2-butylamido-5-sulfonamidoindane DML9MCU Discovery agent N.A. Investigative [19]
2-cyclohexylamido-5-sulfonamidoindane DMFBD3K Discovery agent N.A. Investigative [19]
2-ethylamido-5-sulfonamidoindane DMDY3JQ Discovery agent N.A. Investigative [19]
2-Hydrazinocarbonyl-benzenesulfonamide DMG78U2 Discovery agent N.A. Investigative [23]
2-hydrazinylbenzenesulfonamide DMCNXZM Discovery agent N.A. Investigative [21]
2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide DMXEUDM Discovery agent N.A. Investigative [15]
2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide DMDTRZ2 Discovery agent N.A. Investigative [24]
2-nonylamido-5-sulfonamidoindane DMOGWIK Discovery agent N.A. Investigative [19]
2-oxo-2H-chromene-3-carboxylic acid DMFN769 Discovery agent N.A. Investigative [25]
2-oxo-2H-thiochromene-3-carboxylic acid DMZTCOM Discovery agent N.A. Investigative [25]
2-pentafluorophenylamido-5-sulfonamidoindane DMZ9NCA Discovery agent N.A. Investigative [19]
2-propylamido-5-sulfonamidoindane DMG0I25 Discovery agent N.A. Investigative [19]
2-Sulfamoyl-benzoic acid methyl ester DMAO7DS Discovery agent N.A. Investigative [23]
2-valproylamido-5-sulfonamidoindane DM8XSE3 Discovery agent N.A. Investigative [19]
3-((4-aminophenyl)diazenyl)benzenesulfonamide DM37X04 Discovery agent N.A. Investigative [26]
3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide DMAPZQW Discovery agent N.A. Investigative [26]
3-(3-Phenyl-ureido)-benzenesulfonamide DM314ZE Discovery agent N.A. Investigative [20]
3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide DM18MOH Discovery agent N.A. Investigative [26]
3-Amino-benzenesulfonamide DME0TNA Discovery agent N.A. Investigative [27]
3-bromophenyl-difluoromethanesulfonamide DMXZW3R Discovery agent N.A. Investigative [14]
3-Chloro-4-hydrazino-benzenesulfonamide DMSB5IQ Discovery agent N.A. Investigative [23]
3-Fluoro-4-hydrazino-benzenesulfonamide DMLG69R Discovery agent N.A. Investigative [23]
3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide DMQ09J8 Discovery agent N.A. Investigative [28]
4,4'-thiodipyridine-3-sulfonamide DM0K5JM Discovery agent N.A. Investigative [29]
4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide DM5EP3V Discovery agent N.A. Investigative [26]
4-(2-AMINOETHYL)BENZENESULFONAMIDE DMEK6WX Discovery agent N.A. Investigative [30]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide DMWG706 Discovery agent N.A. Investigative [21]
4-(2-Hydroxy-ethyl)-benzenesulfonamide DM1C5U6 Discovery agent N.A. Investigative [21]
4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide DME6DHX Discovery agent N.A. Investigative [29]
4-(2-Propynylthio)pyridine-3-sulfonamide DMT9RAC Discovery agent N.A. Investigative [29]
4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide DMGVNE3 Discovery agent N.A. Investigative [26]
4-(4-Cyanophenoxy)-3-pyridinesulfonamide DMNEAJH Discovery agent N.A. Investigative [29]
4-(4-Fluorophenoxy)-3-pyridinesulfonamide DMRJLAP Discovery agent N.A. Investigative [29]
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide DMKT20Q Discovery agent N.A. Investigative [29]
4-(Allylamino)-3-pyridinesulfonamide DM6MQCI Discovery agent N.A. Investigative [29]
4-(Carbamolymethylthio)pyridine-3-sulfonamide DM12R4M Discovery agent N.A. Investigative [29]
4-(Cyanomethylthio)pyridine-3-sulfonamide DMZP20H Discovery agent N.A. Investigative [29]
4-(hydroxymethyl)benzenesulfonamide DMR6VWL Discovery agent N.A. Investigative [21]
4-(Methylhydrazino)-3-pyridinesulfonamide DM4BPL1 Discovery agent N.A. Investigative [29]
4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide DMYCV8E Discovery agent N.A. Investigative [29]
4-(Quinolinoxy)-3-pyridinesulfonamide DMPNXFA Discovery agent N.A. Investigative [29]
4-Amino-3-bromo-benzenesulfonamide DMVUCZK Discovery agent N.A. Investigative [21]
4-Amino-3-chloro-benzenesulfonamide DMERTQ4 Discovery agent N.A. Investigative [21]
4-Amino-3-fluoro-benzenesulfonamide DMIQ3VR Discovery agent N.A. Investigative [21]
4-Amino-3-iodo-benzenesulfonamide DMCOYHR Discovery agent N.A. Investigative [21]
4-amino-6-chlorobenzene-1,3-disulfonamide DMIWGZS Discovery agent N.A. Investigative [21]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide DMJZNX6 Discovery agent N.A. Investigative [21]
4-azidobenzenesulfonamide DM7EQ06 Discovery agent N.A. Investigative [31]
4-Benzenesulfonylamino-benzenesulfonamide DMC7HKA Discovery agent N.A. Investigative [20]
4-Benzythiopyridine-3-sulfonamide DMI1EFY Discovery agent N.A. Investigative [29]
4-Ethoxy-3-pyridinesulfonamide DM8WAOR Discovery agent N.A. Investigative [29]
4-ethynyl benzene sulfonamide DMIF1D6 Discovery agent N.A. Investigative [32]
4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide DMGBKN7 Discovery agent N.A. Investigative [17]
4-Hydrazino-3-pyridinesulfonamide DMSZMQU Discovery agent N.A. Investigative [29]
4-Hydrazino-benzenesulfonamide DM49B18 Discovery agent N.A. Investigative [21]
4-Hydrazinocarbonyl-benzenesulfonamide DM8PBEJ Discovery agent N.A. Investigative [23]
4-Methanesulfonylamino-benzenesulfonamide DMPH4C8 Discovery agent N.A. Investigative [20]
4-Methoxy-3-pyridinesulfonamide DMJIX7H Discovery agent N.A. Investigative [29]
4-methylphenyl-difluoromethanesulfonamide DMR5NLM Discovery agent N.A. Investigative [14]
4-Methylthiopyridine-3-sulfonamide DMEB5XP Discovery agent N.A. Investigative [29]
4-nitrophenyl-difluoromethanesulfonamide DM9ETMD Discovery agent N.A. Investigative [14]
4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide DMGXM9C Discovery agent N.A. Investigative [20]
5-Amino-[1,3,4]thiadiazole-2-thiol DMGA47N Discovery agent N.A. Investigative [33]
6-(aminomethyl)-2H-chromen-2-one DMJU9TG Discovery agent N.A. Investigative [25]
6-(hydroxymethyl)-2H-chromen-2-one DM5TOX2 Discovery agent N.A. Investigative [25]
6-Acetyl-7-ethoxy-2H-chromen-2-one DMERKGH Discovery agent N.A. Investigative [34]
6-Acetyl-7-hydroxy-2H-chromen-2-one DM1K0E2 Discovery agent N.A. Investigative [34]
6-acetyl-7-methoxy-2H-chromen-2-one DMXOB2K Discovery agent N.A. Investigative [34]
6-acetyl-7-propoxy-2H-chromen-2-one DMCG8BJ Discovery agent N.A. Investigative [34]
6-Hydroxy-benzothiazole-2-sulfonic acid amide DM2B4S5 Discovery agent N.A. Investigative [21]
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid DM7WH82 Discovery agent N.A. Investigative [25]
6-methyl-2-oxo-2H-chromene-3-carboxylic acid DMZ6HQL Discovery agent N.A. Investigative [25]
7-(benzyloxy)-2H-chromen-2-one DMTKFPW Discovery agent N.A. Investigative [25]
7-butoxy-2H-chromen-2-one DM78C5A Discovery agent N.A. Investigative [25]
7-ethoxy-8-propionyl-2H-chromen-2-one DMYJBPI Discovery agent N.A. Investigative [34]
7-hydroxy-6-propionyl-2H-chromen-2-one DMQ3RVK Discovery agent N.A. Investigative [34]
7-hydroxy-8-propionyl-2H-chromen-2-one DMFKSMW Discovery agent N.A. Investigative [34]
7-hydroxycoumarin DMTMNO7 Discovery agent N.A. Investigative [34]
7-methoxy-2-oxo-2H-chromene-4-carboxylic acid DMJITU0 Discovery agent N.A. Investigative [25]
7-methoxy-8-propionyl-2H-chromen-2-one DMH0UVE Discovery agent N.A. Investigative [34]
7-phenethoxy-2H-chromen-2-one DM8Q267 Discovery agent N.A. Investigative [25]
7-propoxy-2H-chromen-2-one DMD5CB6 Discovery agent N.A. Investigative [25]
8-acetyl-7-(benzyloxy)-2H-chromen-2-one DM4R2EX Discovery agent N.A. Investigative [34]
8-acetyl-7-butoxy-2H-chromen-2-one DMCTWBL Discovery agent N.A. Investigative [34]
8-acetyl-7-ethoxy-2H-chromen-2-one DMDV8UT Discovery agent N.A. Investigative [34]
8-Acetyl-7-hydroxy-2H-chromen-2-one DMAMJW2 Discovery agent N.A. Investigative [34]
8-acetyl-7-methoxy-2H-chromen-2-one DMZSJRC Discovery agent N.A. Investigative [34]
8-acetyl-7-propoxy-2H-chromen-2-one DMGRK3V Discovery agent N.A. Investigative [34]
8-methoxy-2-oxo-2H-chromene-3-carboxylic acid DMHCWY8 Discovery agent N.A. Investigative [25]
8-Propionyl-7-propoxy-2H-chromen-2-one DMKWYJX Discovery agent N.A. Investigative [34]
ACETYLSULFANILAMIDE DMG8P24 Discovery agent N.A. Investigative [20]
Aminobenzolamide derivative DMWYS0Z Discovery agent N.A. Investigative [35]
Azide DM5XZYB Discovery agent N.A. Investigative [36]
BENZOLAMIDE DME5QPX Discovery agent N.A. Investigative [21]
Bicarbonate DMT5E36 Discovery agent N.A. Investigative [11]
Carzenide DMVD481 Discovery agent N.A. Investigative [21]
CATECHIN DMY38SB Discovery agent N.A. Investigative [2]
CL-5343 DM9AFZ3 Solid tumour/cancer 2A00-2F9Z Investigative [37]
Coumarin DM0N8ZM Discovery agent N.A. Investigative [25]
Decane-1,10-diyl disulfamate DM1ESVR Discovery agent N.A. Investigative [38]
Decyl sulfamate DMIERWO Discovery agent N.A. Investigative [38]
ELLAGIC ACID DMX8BS5 Discovery agent N.A. Investigative [3]
ETHOXYCOUMARIN DMSKU4M Discovery agent N.A. Investigative [25]
Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate DMWIB0V Discovery agent N.A. Investigative [25]
GALLICACID DM6Y3A0 Discovery agent N.A. Investigative [3]
HERNIARIN DM9UASM Discovery agent N.A. Investigative [25]
Hexane-1,6-diamine DMSHF0K Discovery agent N.A. Investigative [13]
HYDROSULFIDE DMO32HN Discovery agent N.A. Investigative [36]
MMI270 DM38N2K Discovery agent N.A. Investigative [22]
N-(4-cyanophenyl)sulfamide DMW8S2D Discovery agent N.A. Investigative [39]
N-(4-Sulfamoyl-phenyl)-benzamide DMZDACT Discovery agent N.A. Investigative [20]
N-(4-Sulfamoyl-phenyl)-butyramide DM3FW9Q Discovery agent N.A. Investigative [20]
N-(4-Sulfamoyl-phenyl)-isobutyramide DMJCXYQ Discovery agent N.A. Investigative [20]
N-(4-Sulfamoyl-phenyl)-propionamide DM7MHQD Discovery agent N.A. Investigative [20]
N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide DM7QX03 Discovery agent N.A. Investigative [40]
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide DMSQEXP Discovery agent N.A. Investigative [33]
N-(pentafluorophenyl)sulfamide DME45J8 Discovery agent N.A. Investigative [39]
N-hydroxysulfamide DMTDBMU Discovery agent N.A. Investigative [41]
N-propynyl amidebenzenesulphonide DMWTPJH Discovery agent N.A. Investigative [42]
N1-(2-aminoethyl)ethane-1,2-diamine DM6HM5S Discovery agent N.A. Investigative [13]
N1-(naphthalen-1-yl)ethane-1,2-diamine DMYGCSV Discovery agent N.A. Investigative [13]
NSC-654077 DMW3QAK Discovery agent N.A. Investigative [15]
Octane-1,8-diyl disulfamate DMBQMGH Discovery agent N.A. Investigative [38]
Octyl sulfamate DM40ZCA Discovery agent N.A. Investigative [38]
P-Coumaric Acid DMGJSVD Discovery agent N.A. Investigative [3]
P-toluenesulfonamide DMPEKTO Discovery agent N.A. Investigative [21]
Pentane-1,5-diamine DMVPZG9 Discovery agent N.A. Investigative [13]
Pentanoic acid (4-sulfamoyl-phenyl)-amide DMAZ07T Discovery agent N.A. Investigative [20]
PHENYLDIFLUOROMETHANESULFONAMIDE DME75VC Discovery agent N.A. Investigative [14]
PHENYLMETHANESULFONAMIDE DMGLDFI Discovery agent N.A. Investigative [14]
PHENYLSULFAMATE DMRLFJV Discovery agent N.A. Investigative [14]
Prop-2-ynyl 4-sulfamoylbenzoate DM8O41M Discovery agent N.A. Investigative [42]
Quinoline-8-sulfonamide DMTPFLU Discovery agent N.A. Investigative [17]
Saccharin DMRA736 Discovery agent N.A. Investigative [43]
Sodium N-methylphenylaminomethanesulfonate DMBVQI4 Discovery agent N.A. Investigative [26]
Sodium phenylaminomethanesulfonate DMJ7I4U Discovery agent N.A. Investigative [26]
SULFAMATE DMF1589 Discovery agent N.A. Investigative [11]
Sulfamic acid 12-sulfamoyloxy-dodecyl ester DM9XNSK Discovery agent N.A. Investigative [44]
Sulfamic acid 16-sulfamoyloxy-hexadecyl ester DM7VBSY Discovery agent N.A. Investigative [44]
Sulfamic acid 3-sulfamoyloxy-phenyl ester DMA0MEV Discovery agent N.A. Investigative [44]
Sulfamic acid 4-sulfamoyloxy-butyl ester DMQZGNJ Discovery agent N.A. Investigative [44]
Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester DMFJR0S Discovery agent N.A. Investigative [44]
Sulfamic acid 6-sulfamoyloxy-hexyl ester DMT3U2D Discovery agent N.A. Investigative [44]
Sulfamic acid 7-sulfamoyloxy-heptyl ester DMVWEN3 Discovery agent N.A. Investigative [44]
Syringic Acid DM802V7 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 168 Investigative Drug(s)

Molecular Expression Atlas (MEA) of This DTT

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DTT
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Renal cancer 2C82 Kidney 6.08E-15 2.8 7.25
Breast cancer 2C82 Breast tissue 1.12E-10 -0.03 -0.09
------------------------------------------------------------------------------------

References

1 Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem. 2010 Apr 8;53(7):2913-26.
2 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
3 Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
4 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-r... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6.
5 Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics. 2012;6:395-407.
6 Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab. J Nucl Med. 2014 Jun;55(6):1035-40.
7 Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-assoc... Bioorg Med Chem Lett. 2004 Jan 5;14(1):217-23.
8 Development of small molecule carbonic anhydrase IX inhibitors.BJU Int.2008 Jun;101 Suppl 4:39-40.
9 Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int J Mol Sci. 2013 May 29;14(6):11402-23.
10 Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Mol Cancer Ther. 2012 Feb;11(2):340-9.
11 Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbo... Bioorg Med Chem Lett. 2005 Feb 1;15(3):567-71.
12 Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).Expert Opin Ther Pat. 2018 Oct;28(10):729-740.
13 Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
14 Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6.
15 Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem. 2008 Jun 12;51(11):3051-6.
16 Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the... Eur J Med Chem. 2010 Sep;45(9):3656-61.
17 Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorg Med Chem. 2009 Jan 15;17(2):553-7.
18 N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4316-20.
19 Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9.
20 Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4862-6.
21 Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
22 Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with su... Bioorg Med Chem. 2007 Mar 15;15(6):2298-311.
23 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamide... J Med Chem. 2005 Mar 24;48(6):2121-5.
24 Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic... Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72.
25 Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
26 Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the... Bioorg Med Chem. 2009 Oct 15;17(20):7093-9.
27 Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3828-33.
28 Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J Med Chem. 2006 Sep 7;49(18):5544-51.
29 Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associa... Eur J Med Chem. 2010 Jun;45(6):2396-404.
30 Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-media... J Med Chem. 2005 Jul 28;48(15):4834-41.
31 Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2273-6.
32 Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. J Med Chem. 2008 Mar 27;51(6):1945-53.
33 Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-th... Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.
34 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and X... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8.
35 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides d... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.
36 Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5769-73.
37 Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a l... Bioorg Med Chem Lett. 2010 Aug 1;20(15):4376-81.
38 Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-bi... J Med Chem. 2009 Oct 8;52(19):5990-8.
39 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxy... Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8.
40 Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity. Bioorg Med Chem. 2010 Jul 15;18(14):5081-9.
41 Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5.
42 A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". J Med Chem. 2006 Nov 2;49(22):6539-48.
43 Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of... Bioorg Med Chem Lett. 2008 Jan 15;18(2):836-41.
44 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.